India helps pharmas compete for WHO contracts

The Indian government is planning a subsidy scheme for mid-size drugmakers to bring their facilities in line with WHO manufacturing standards. Most already comply with the standards of the country's Drugs and Cosmetics Act, so officials believe that the facility upgrades will be of limited scope. A proposal now in the works provides an interest subsidy to the qualifying companies. Article

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.